Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Depreciation & Amortization - Total: 2022-2025

Historic Depreciation & Amortization - Total for InMed Pharmaceuticals (INM) over the last 2 years, with Jun 2025 value amounting to $12,206.

  • InMed Pharmaceuticals' Depreciation & Amortization - Total rose 124.37% to $12,206 in Q2 2025 from the same period last year, while for Jun 2025 it was $50,204, marking a year-over-year increase of 5.16%. This contributed to the annual value of $50,204 for FY2025, which is 5.16% up from last year.
  • Per InMed Pharmaceuticals' latest filing, its Depreciation & Amortization - Total stood at $12,206 for Q2 2025, which was up 0.02% from $12,203 recorded in Q1 2025.
  • InMed Pharmaceuticals' Depreciation & Amortization - Total's 5-year high stood at $14,242 during Q4 2023, with a 5-year trough of $5,440 in Q2 2024.
  • In the last 3 years, InMed Pharmaceuticals' Depreciation & Amortization - Total had a median value of $12,562 in 2023 and averaged $12,145.
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first crashed by 57.88% in 2024, then surged by 124.37% in 2025.
  • Over the past 4 years, InMed Pharmaceuticals' Depreciation & Amortization - Total (Quarterly) stood at $8,055 in 2022, then surged by 76.81% to $14,242 in 2023, then declined by 14.27% to $12,209 in 2024, then soared by 124.37% to $12,206 in 2025.
  • Its Depreciation & Amortization - Total was $12,206 in Q2 2025, compared to $12,203 in Q1 2025 and $12,209 in Q4 2024.